I agree Trding, it is apparent that they are not sure the price as they have changed it from $24,000 to $70,000 to $120,000 over the last couple of months. I am sure they will do their best to price it accordingly and without doing further research that in the ballpark of $70,000 is most likely if/once anything other than combo is approved. Hopefully $70,000 isn’t too high for mono as they stated it will be difficult to price differently across various treatments.
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.